RENMAB Trademark

Trademark Overview


On Wednesday, July 31, 2019, a trademark application was filed for RENMAB with the United States Patent and Trademark Office. The USPTO has given the RENMAB trademark a serial number of 88553807. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 19, 2024. This trademark is owned by Beijing Biocytogen Co., Ltd.. The RENMAB trademark is filed in the Chemical Products, Pharmaceutical Products, Natural Agricultural Products, and Computer & Software Services & Scientific Services categories with the following description:

Medical immunoassay reagent derived from experimental animals; medical biological preparations for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; drugs for treating cancer, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; medicines for human purposes, namely, for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; biochemical drugs for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; immunologic stimulants for medical use for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; bulk drugs for the treatment of diseases, namely, Active Biopharmaceutical Ingredients derived from experimental animals; medical diagnostic preparation, namely, antibodies and proteins for biopharmaceuticals ...

Chemical additives for insecticides; nitrogen fertilizer; food preservative chemicals; biological preparations not for medical or veterinary use; radioactive elements for scientific purposes; diagnostic preparations not for medical or veterinary use; protein in raw material form for scientific and medical research, and industrial use; plasticizers being industrial chemicals; industrial adhesives; industrial chemicals, not for medical use

(Based on 44(e)) Drug development services for others provided via a platform for antibody discovery that features experimental animal research; drug evaluations being pharmaceutical research provided via a platform for antibody discovery that features experimental animal research; pharmaceutical research provided via a platform for antibody discovery that features experimental animal research; Implementation of early assessment in new drug development fields for others, involving experimental animals, to support the development by others of pharmaceutical preparations and medicines; development of pharmaceutical preparations and medicines provided via a platform for antibody discovery that features experimental animal research; clinical trials being pharmaceutical and scientific research services provided via a platform for antibody discovery that features experimental animal research; package design; research and development of antibodies provided via a platform for antibody discover...

(Based on 44(e)) Live experimental animal; live animals; live poultry; live hamster; live swine; living trees; plant seeds; hay; living plants
renmab

General Information


Serial Number88553807
Word MarkRENMAB
Filing DateWednesday, July 31, 2019
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements


Goods and ServicesMedical immunoassay reagent derived from experimental animals; medical biological preparations for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; drugs for treating cancer, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; medicines for human purposes, namely, for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; biochemical drugs for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; immunologic stimulants for medical use for the treatment of diseases, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals; bulk drugs for the treatment of diseases, namely, Active Biopharmaceutical Ingredients derived from experimental animals; medical diagnostic preparation, namely, antibodies and proteins for biopharmaceuticals derived from experimental animals
Translation of Words in MarkThe wording "RENMAB" has no meaning in a foreign language.
Goods and ServicesChemical additives for insecticides; nitrogen fertilizer; food preservative chemicals; biological preparations not for medical or veterinary use; radioactive elements for scientific purposes; diagnostic preparations not for medical or veterinary use; protein in raw material form for scientific and medical research, and industrial use; plasticizers being industrial chemicals; industrial adhesives; industrial chemicals, not for medical use
Goods and Services(Based on 44(e)) Drug development services for others provided via a platform for antibody discovery that features experimental animal research; drug evaluations being pharmaceutical research provided via a platform for antibody discovery that features experimental animal research; pharmaceutical research provided via a platform for antibody discovery that features experimental animal research; Implementation of early assessment in new drug development fields for others, involving experimental animals, to support the development by others of pharmaceutical preparations and medicines; development of pharmaceutical preparations and medicines provided via a platform for antibody discovery that features experimental animal research; clinical trials being pharmaceutical and scientific research services provided via a platform for antibody discovery that features experimental animal research; package design; research and development of antibodies provided via a platform for antibody discovery that features experimental animal research; research and development of new products for others provided via a platform for antibody discovery that features experimental animal research; products development for others provided via a platform for antibody discovery that features experimental animal research; consulting services in biotechnology development fields involving experimental animal research and antibodies discovered from the same, the aforementioned also provided via a platform for antibody discovery that features experimental animal research; biological research and analyses provided via a platform for antibody discovery that features experimental animal research; biochemistry research and analyses provided via a platform for antibody discovery that features experimental animal research; biotechnology research provided via a platform for antibody discovery that features experimental animal research
Goods and Services(Based on 44(e)) Live experimental animal; live animals; live poultry; live hamster; live swine; living trees; plant seeds; hay; living plants

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, August 14, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 14, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt.
US Class Codes001, 046
Class Status Code6 - Active
Class Status DateWednesday, August 14, 2019
Primary Code031
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 14, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIOCYTOGEN PHARMACEUTICALS (BEIJING) CO.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBEIJING 100176
CN

Party NameBIOCYTOGEN PHARMACEUTICALS (BEIJING) CO.
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressBEIJING 100176
CN

Party NameBeijing Biocytogen Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBeijing 100176
CN

Trademark Events


Event DateEvent Description
Saturday, August 3, 2019NEW APPLICATION ENTERED
Wednesday, August 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 28, 2019ASSIGNED TO EXAMINER
Tuesday, November 5, 2019NON-FINAL ACTION WRITTEN
Tuesday, November 5, 2019NON-FINAL ACTION E-MAILED
Tuesday, November 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 5, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 8, 2020ASSIGNED TO LIE
Tuesday, May 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 29, 2020SUSPENSION LETTER WRITTEN
Friday, May 29, 2020LETTER OF SUSPENSION E-MAILED
Friday, May 29, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 2, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, January 5, 2021SUSPENSION INQUIRY WRITTEN
Tuesday, January 5, 2021INQUIRY TO SUSPENSION E-MAILED
Tuesday, January 5, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, February 17, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 6, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, July 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 15, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, February 14, 2022OPPOSITION INSTITUTED NO. 999999
Monday, October 21, 2024OPPOSITION DISMISSED NO. 999999
Monday, October 21, 2024TTAB RELEASE CASE TO TRADEMARKS
Tuesday, November 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 21, 2024OPPOSITION TERMINATED NO. 999999